Literature DB >> 9475350

Oral tolerance.

W Strober1, B Kelsall, T Marth.   

Abstract

Oral tolerance is the immunologic mechanism by which the mucosal immune system maintains unresponsiveness to the myriad of antigens in the mucosal environment which might otherwise induce untoward immune responses. Recent studies have shown that it is mediated by several distinct, yet interacting mechanisms including the generation of suppressive T cells producing antigen nonspecific cytokines and the induction of clonal deletion and/or anergy. In this review of oral tolerance, we discuss these mechanisms in detail and show how oral tolerance or lack thereof may explain the occurrence of mucosal inflammation. In addition, we discuss how induction of oral tolerance can be used to treat autoimmune states.

Entities:  

Mesh:

Year:  1998        PMID: 9475350     DOI: 10.1023/a:1023222003039

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  124 in total

Review 1.  Oral tolerance for the treatment of autoimmune diseases.

Authors:  H L Weiner
Journal:  Annu Rev Med       Date:  1997       Impact factor: 13.739

2.  Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.

Authors:  M Marinaro; H F Staats; T Hiroi; R J Jackson; M Coste; P N Boyaka; N Okahashi; M Yamamoto; H Kiyono; H Bluethmann; K Fujihashi; J R McGhee
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

3.  CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice.

Authors:  I Takahashi; H Kiyono; S Hamada
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

4.  In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis.

Authors:  J I Inobe; Y Chen; H L Weiner
Journal:  Ann N Y Acad Sci       Date:  1996-02-13       Impact factor: 5.691

Review 5.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats.

Authors:  H S Thompson; N A Staines
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

7.  Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.

Authors:  Y Chen; J Inobe; V K Kuchroo; J L Baron; C A Janeway; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

Review 8.  Intraepithelial lymphocytes and their recognition of non-classical MHC molecules.

Authors:  R S Blumberg; S P Balk
Journal:  Int Rev Immunol       Date:  1994       Impact factor: 5.311

9.  Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.

Authors:  J Tian; M A Atkinson; M Clare-Salzler; A Herschenfeld; T Forsthuber; P V Lehmann; D L Kaufman
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

Authors:  F Powrie; R Correa-Oliveira; S Mauze; R L Coffman
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  21 in total

Review 1.  The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease.

Authors:  W Strober; K Nakamura; A Kitani
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Haiping Qiao; Diane Dryja; Allen Leavens; Jon Rossman; Gary Rich; Douglas Dirienzo; Pearay L Ogra
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

3.  Enteroendocrine cells express functional Toll-like receptors.

Authors:  Milena Bogunovic; Shaival H Davé; Jeremy S Tilstra; Diane T W Chang; Noam Harpaz; Huabao Xiong; Lloyd F Mayer; Scott E Plevy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-03-29       Impact factor: 4.052

4.  Diminution of Circulating CD4+CD25 high T cells in naïve Crohn's disease.

Authors:  Patrick Chamouard; Fanny Monneaux; Zoe Richert; Anne-Claire Voegeli; Thomas Lavaux; Marie Pierre Gaub; René Baumann; Pierre Oudet; Sylviane Muller
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

5.  Are we getting enough allergens?

Authors:  Allan Linneberg
Journal:  Int Arch Allergy Immunol       Date:  2008-06-03       Impact factor: 2.749

6.  CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation.

Authors:  A M Westendorf; M Templin; R Geffers; S Deppenmeier; A D Gruber; M Probst-Kepper; W Hansen; R S Liblau; F Gunzer; D Bruder; J Buer
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

7.  Lamina propria lymphocytes produce interferon-gamma and develop suppressor activity in response to lactoglobulin.

Authors:  E C Ebert; A I Roberts
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

8.  Peyer's patches are required for oral tolerance to proteins.

Authors:  K Fujihashi; T Dohi; P D Rennert; M Yamamoto; T Koga; H Kiyono; J R McGhee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

9.  TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis.

Authors:  B Del Zotto; G Mumolo; A M Pronio; C Montesani; R Tersigni; M Boirivant
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

10.  Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells.

Authors:  Hideaki Suzuki; Shinichi Sekine; Kosuke Kataoka; David W Pascual; Massimo Maddaloni; Ryoki Kobayashi; Keiko Fujihashi; Haruo Kozono; Jerry R McGhee; Kohtaro Fujihashi
Journal:  Gastroenterology       Date:  2008-05-15       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.